S&T Bank’s TG Therapeutics TGTX Stock Holding History

S&T Bank’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-170	Closed	-$6.12K	–	528
2025 Q2	$6.12K	Hold	170	–	–	﹤0.01%	279
2025 Q1	$6.7K	Buy	+170	New	+$5.72K	﹤0.01%	253

Other funds holding TGTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

S&T Bank's TGTX Position: Q3 2025 in Review

S&T Bank sold out of TG Therapeutics (TGTX) in Q3 2025, closing a stake of 170 shares — an estimated $6.12K sold.

S&T Bank first reported a position in TGTX in Q1 2025 and held it in 2 quarters. The position peaked at $6.7K in Q1 2025. 354 funds tracked by Wall St. Rank hold TGTX as of Q3 2025.

S&T Bank reported no remaining TG Therapeutics position as of Q3 2025 after selling out during the quarter.
S&T Bank sold 170 TG Therapeutics shares in Q3 2025, an estimated $6.12K.
S&T Bank first reported a position in TG Therapeutics in Q1 2025 and held it in 2 quarters.
S&T Bank's TG Therapeutics position peaked at $6.7K in Q1 2025.
354 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2025.

Based on S&T Bank's 13F filing for Q3 2025, filed 14 Nov 2025.